Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs
Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares…
Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs
Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares in a private placement alongside the biotech’s IPO. Windward’s lead drug candidate addresses the same target as a blockbuster asthma drug from partners Amgen and AstraZeneca. The post Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs…
What the Recent Elections and an Evolving Federal Policy Landscape Could Mean for Medicaid Expansion Efforts in 2027
Among the ten states that have not adopted the Medicaid expansion, Georgia, Kansas, Texas and Wisconsin are key states to watch for potential new debates about expansion given the outcome of the elections.
What’s Missing from Healthcare Quality Conversations?
[Sponsored] Jason Tibbels, MD, Lantern Chief Medical Officer, described the company’s approach to making care more affordable without undermining quality or health outcomes in an interview with MedCity News Editor-in-Chief Arundhati Parmar at INVEST Digital Health. The post What’s Missing from Healthcare Quality Conversations? appeared first on MedCity News.
Second-Year Rural Health Fund Awards Per Rural Resident Continue to Vary Widely
This analysis describes rural health fund awards in the second year of the program. Awards per rural resident continue to vary widely across states in year two, ranging from less than $100 in twelve states to more than $500 in eight states
Pay Transparency in Life Sciences: Staying Ahead of Emerging Regulatory Complexity
In an industry characterized by intense competition for specialized and high-level talent and complex compensation structures, leaders must treat pay transparency not merely as a compliance requirement, but as a strategic priority requiring strong internal alignment across an evolving global landscape. The post Pay Transparency in Life Sciences: Staying Ahead of Emerging Regulatory Complexity appeared…
How Politics Became Every Hospital’s Brand Risk
When governments fall short on public health, hospitals inherit the fallout. Those with the strongest brands are best positioned to withstand it. The post How Politics Became Every Hospital’s Brand Risk appeared first on MedCity News.
What Healthcare Boards Need to Know Post-Midterms
A new Congress and H.R. 1’s Medicaid provisions could reshape healthcare policy and provider operations in 2027
Midterms Put Medicaid and Rural Healthcare Back in Focus
Rural hospitals operate on thin margins, and changes to Medicaid funding could affect access to preventive, behavioral, and chronic care
Rules Governing Human Oversight of AI in Health Care Could Shape Public Trust — The Monitor
New regulations and guidelines for the use of AI in health care have sought to answer questions about human oversight and accountability. Separately, a new HHS initiative aims to expand research into potential vaccine injuries, but some medical organizations have questioned how the efforts may be perceived.
Health Data Access Advances, but Privacy and Security Must Keep Pace, Panelists Say
Panelists emphasized that patients need their information available when they seek care, while also understanding how it is being used and protected
